Annals of Coloproctology

Editorial

Dynamics of the microbiota in right-sided colon cancer patients: pre- and post-tumor resection: Youn Young Park; Ann Coloproctol. 2025;41(1):1-2. Published online February 28, 2025; DOI: https://doi.org/10.3393/ac.2025.00094.0013

222 View
29 Download

PDF

Case Report

Metachronous carcinoma at the colostomy site after abdominoperineal resection of rectal cancer: a case report: Young Sun Choi, Kil-young Lee, Youn Young Park, Hyung Jin Kim, Jaeim Lee; Ann Coloproctol. 2023;39(2):175-177. Published online July 27, 2021; DOI: https://doi.org/10.3393/ac.2020.00185.0026

3,758 View
157 Download
3 Web of Science
3 Citations

Metachronous carcinoma at the colostomy site is very rare after abdominoperineal resection. A 53-year-old male patient underwent an abdominoperineal resection 6 years earlier for rectal cancer developed metachronous carcinoma at the site of stoma. A portion of the colon, including the stoma and the surrounding skin, was resected and a new stoma was created in the transverse colon. Although the occurrence of carcinoma at the stoma site is a rare condition, careful observation for the stoma and colonoscopy for surveillance are necessary.

Citations

Citations to this article as recorded by

Colostomy‐site carcinoma with primitive phenotype in a rectal cancer patient after achieving pathological complete response with neoadjuvant chemoradiotherapy
Takayuki Kodama, Maki Kanzawa, Hiroshi Hasegawa, Shuichi Tsukamoto, Mari Nishio, Manabu Shigeoka, Yu‐ichiro Koma, Tomoo Itoh, Hiroshi Yokozaki
Pathology International.2024; 74(1): 33. CrossRef
Metachronous Carcinoma at Colostomy Site Post Abdominoperineal Resection – A Rare Presentation Case Report
Muhammed Huzaifa, Ankita Singh, Vaibhav Aggarwal, Anita Dhar
Clinical Cancer Investigation Journal.2023; 12(2): 1. CrossRef
Peristomal adenocarcinoma 16 years after colorectal adenocarcinoma resection with curative intent
Kayleigh A M van Dam, Thaís T T Tweed, Bart de Vries, Henricus J Belgers
Journal of Surgical Case Reports.2023;[Epub] CrossRef

Original Articles

Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients: Youn Young Park, Kang Young Lee, Nam Kyu Kim, Sat Byol Lee, Ga Ram Kim, Byung Soh Min, Seong-Taek Oh; Ann Coloproctol. 2019;35(6):335-341. Published online December 31, 2019; DOI: https://doi.org/10.3393/ac.2019.03.10

3,686 View
62 Download
2 Web of Science
2 Citations

Abstract PDF

Purpose
Adjuvant chemotherapy (aCT) in rectal cancer patients who have undergone curative resection after neoadjuvant chemoradiation (nCRT) is controversial. We aimed to investigate the benefits of using aCT and the clinical impact of completing aCT in ypstage 2 rectal cancer patients.
Methods
We retrospectively reviewed clinicopathological data from patients who had undergone radical resection after nCRT between January 2006 and December 2012. In total, 152 patients with ypT3/4N0M0 rectal cancer were included. Of these patients, 139 initiated aCT, while 13 did not receive aCT (no-aCT). Among those who received aCT, 132 patients completed their planned cycles (aCT-completion) whereas 7 did not (aCT-incompletion). All patients received longcourse chemoradiation; a 5-fluorouracil-based regimen was used for nCRT in most patients. The prognostic factors affecting disease-free survival (DFS) and overall survival (OS) were analyzed.
Results
The median follow-up duration was 41 months. Demographic data did not differ significantly among the 3 groups. In multivariate analysis, open surgery, a tumor size >2 cm, retrieval of <12 lymph nodes, circumferential resection margin (CRM) positivity and aCT incompletion were independent prognostic factors for poor DFS. Old age (≥60 years), open surgery, CRM positivity, aCT incompletion, and lack of aCT initiation compared to aCT completion were independent prognostic factors for poor OS.
Conclusion
In ypstage 2 rectal cancer patients, aCT after nCRT and total mesorectal excision affected both DFS and OS; however, only patients who completed planned aCT exhibited survival benefits. Therefore, improving patients’ compliance with the completion of aCT is desirable.

Citations

Citations to this article as recorded by

Adjuvant chemotherapy in locally advanced rectal cancer after neo-adjuvant concurrent chemoradiotherapy and surgery: A retrospective study in Vietnamese patients
Thang Tran, Huy Van Nguyen, Hoa Thi Nguyen, Hung Van Nguyen
Annals of Medicine & Surgery.2023; 85(9): 4234. CrossRef
Watch and wait strategies for rectal cancer: A systematic review
In Ja Park
Precision and Future Medicine.2022; 6(2): 91. CrossRef

Short-term Outcomes After Upfront Chemotherapy Followed by Curative Surgery in Metastatic Colon Cancer: A Comparison With Upfront Surgery Patients: Myung Hyun Han, Youn Young Park, Shiva Pratap, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim; Ann Coloproctol. 2019;35(6):327-334. Published online December 31, 2019; DOI: https://doi.org/10.3393/ac.2019.03.04.1

3,378 View
69 Download
2 Web of Science
2 Citations

Abstract PDF

Purpose
Upfront systemic chemotherapy with target agents has been recommended for patients with stage IV colon cancer. Some with partial response are considered for curative resection. There is high risk of developing postoperative complications following upfront systemic chemotherapy. We aimed to evaluate short-term perioperative outcomes of curative surgery after upfront chemotherapy in comparison with upfront surgery in patients with metastatic colon cancer.
Methods
Between January 2010 and October 2015, 146 patients (80 in the surgery first group, 66 in the upfront chemotherapy group) who underwent surgical resection before or after systemic chemotherapy for metastatic colon cancer were included in the present study. All decisions for treatment were made through a multidisciplinary team. Postoperative clinical outcomes and complications were analyzed to compare the groups.
Results
There was no difference between the 2 groups in terms of postoperative clinical outcomes. Overall complication rates were not different between the groups (surgery first group: 46.3% vs. upfront chemotherapy group: 60.6%; P = 0.084). When classified according to the Clavien-Dindo method, there was no difference between the 2 groups in terms of major complications (grade 3 or more) (surgery first group: 18.9% vs. upfront chemotherapy group: 27.5%; P = 0.374).
Conclusion
There was no significant increase in major postoperative complications in metastatic colon cancer patients who received upfront chemotherapy followed by curative surgery. Careful patient selection and treatment planning are important.

Citations

Citations to this article as recorded by

Impact of preoperative chemotherapy on perioperative morbidity in combined resection of colon cancer and liver metastases
Joy Z. Done, Angelos Papanikolaou, Miloslawa Stem, Shannon N. Radomski, Sophia Y. Chen, Chady Atallah, Jonathan E. Efron, Bashar Safar
Journal of Gastrointestinal Surgery.2023; 27(11): 2380. CrossRef
Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer
Young Jin Kim, Chang Hyun Kim
Annals of Coloproctology.2021; 37(6): 425. CrossRef

Influence of Shorter Duration of Prophylactic Antibiotic Use on the Incidence of Surgical Site Infection Following Colorectal Cancer Surgery: Youn Young Park, Chang Woo Kim, Sun Jin Park, Kil Yeon Lee, Jung Joo Lee, Hye Ok Lee, Suk-Hwan Lee; Ann Coloproctol. 2015;31(6):235-242. Published online December 31, 2015; DOI: https://doi.org/10.3393/ac.2015.31.6.235

5,229 View
56 Download
15 Web of Science
16 Citations

Abstract PDF

Purpose

This study aimed to identify the risk factors for surgical site infections (SSIs) in patients undergoing colorectal cancer surgery and to determine whether significantly different SSI rates existed between the short prophylactic antibiotic use group (within 24 hours) and the long prophylactic antibiotic use group (beyond 24 hours).

Methods

The medical records of 327 patients who underwent colorectal resection due to colorectal cancer from January 2010 to May 2014 at a single center were retrospectively reviewed, and their characteristics as well as the surgical factors known to be risk factors for SSIs, were identified.

Results

Among the 327 patients, 45 patients (13.8%) developed SSIs. The patients were divided into two groups according to the duration of antibiotic use: group S (within 24 hours) and group L (beyond 24 hours). Of the 327 patients, 114 (34.9%) were in group S, and 213 (65.1%) were in group L. Twelve patients (10.5%) in group S developed SSIs while 33 patients (15.5%) in group L developed SSIs (P = 0.242). History of diabetes mellitus and lung disease, long operation time, and perioperative transfusion were independent risk factors for SSIs.

Conclusion

This study shows that discontinuation of prophylactic antibiotics within 24 hours after colorectal surgery has no significant influence on the incidence of SSIs. This study also showed that history of diabetes mellitus and lung disease, long operation time, and perioperative transfusion were associated with increased SSI rates.

Citations

Citations to this article as recorded by

RETRACTED: A meta‐analysis of the risk factors for surgical site infection in patients with colorectal cancer
Yani Chen, Hua Guo, Tian Gao, Jiale Yu, Yujia Wang, Haiquan Yu
International Wound Journal.2024;[Epub] CrossRef
Evaluation after implementation of chemical bowel preparation for surgical site infections in elective colorectal cancer surgery and role of antimicrobial stewardship pharmacist: Retrospective cohort study
Yasuhiro Sasaki, Akira Kurishima, Chieko Miyamoto, Kenichiro Hataji, Toru Tezuka, Hideo Katsuragawa
Journal of Pharmaceutical Health Care and Sciences.2024;[Epub] CrossRef
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?
Mingyue Xu, Yuanyuan Chen, Panhua Li, Qianwen Ye, Shouhan Feng, Bing Yan
BMC Cancer.2024;[Epub] CrossRef
Surgical Site Infections in Colorectal Cancer Surgeries: A Systematic Review and Meta-Analysis of the Impact of Surgical Approach and Associated Risk Factors
Valentin Calu, Catalin Piriianu, Adrian Miron, Valentin Titus Grigorean
Life.2024; 14(7): 850. CrossRef
Potent antibacterial activity in surgical wounds with local administration of D-PLEX100
Noam Emanuel, Goldi A. Kozloski, Shlomo Nedvetzki, Sefi Rosenfeld
European Journal of Pharmaceutical Sciences.2023; 188: 106504. CrossRef
Worldwide incidence of surgical site infections in general surgical patients: A systematic review and meta-analysis of 488,594 patients
Brigid M. Gillespie, Emma Harbeck, Megan Rattray, Rhea Liang, Rachel Walker, Sharon Latimer, Lukman Thalib, Annette Erichsen Andersson, Bronwyn Griffin, Robert Ware, Wendy Chaboyer
International Journal of Surgery.2021; 95: 106136. CrossRef
Risk factors for surgical site infection in patients undergoing colorectal surgery: A meta-analysis of observational studies
ZhaoHui Xu, Hui Qu, ZeZhong Gong, George Kanani, Fan Zhang, YanYing Ren, Shuai Shao, XiaoLiang Chen, Xin Chen, Zubing Mei
PLOS ONE.2021; 16(10): e0259107. CrossRef
Update on risk factors of surgical site infection in colorectal cancer: a systematic review and meta-analysis
Zhaohui Xu, Hui Qu, George Kanani, Zhong Guo, Yanying Ren, Xin Chen
International Journal of Colorectal Disease.2020; 35(12): 2147. CrossRef
Appropriate Prophylactic Antibiotic Use in Clean Wound Surgery Under Local Anesthesia
Han Gyu Cha, Jin Geun Kwon, Hyun Ho Han, Jin Sup Eom, Eun Key Kim
Journal of Korean Medical Science.2019;[Epub] CrossRef
Patterns of antibiotics and pathogens for anastomotic leakage after colorectal cancer surgery
Geunhyeok Yang, Chang Woo Kim, Suk-Hwan Lee
Korean Journal of Clinical Oncology.2019; 15(2): 79. CrossRef
Challenging surgical dogma in the management of proximal esophageal atresia with distal tracheoesophageal fistula: Outcomes from the Midwest Pediatric Surgery Consortium
Dave R. Lal, Samir K. Gadepalli, Cynthia D. Downard, Daniel J. Ostlie, Peter C. Minneci, Ruth M. Swedler, Thomas H. Chelius, Laura Cassidy, Cooper T. Rapp, Deborah Billmire, Steven Bruch, R. Carland Burns, Katherine J. Deans, Mary E. Fallat, Jason D. Fras
Journal of Pediatric Surgery.2018; 53(7): 1267. CrossRef
Comparison of intraoperative handling and wound healing between (NEOSORB® plus) and coated polyglactin 910 suture (NEOSORB®): a prospective, single-blind, randomized controlled trial
Bum Sik Tae, Ju Hyun Park, Jung Kwon Kim, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Chang Wook Jeong
BMC Surgery.2018;[Epub] CrossRef
Impact of a change in duration of prophylactic antibiotics on infectious complications after radical cystectomy with a neobladder
Chung-Jong Kim, Kwang Hyun Kim, Wan Song, Dong Hyeon Lee, Hee Jung Choi
Medicine.2018; 97(47): e13196. CrossRef
Colorectal surgery and surgical site infection: is a change of attitude necessary?
Manuela Elia-Guedea, Elena Cordoba-Diaz de Laspra, Estibaliz Echazarreta-Gallego, María Isabel Valero-Lazaro, Jose Manuel Ramirez-Rodriguez, Vicente Aguilella-Diago
International Journal of Colorectal Disease.2017; 32(7): 967. CrossRef
Influence of a Shorter Duration of Post-Operative Antibiotic Prophylaxis on Infectious Complications in Patients Undergoing Elective Liver Resection
Masahiko Sakoda, Satoshi Iino, Yuko Mataki, Yota Kawasaki, Hiroshi Kurahara, Kosei Maemura, Shinichi Ueno, Shoji Natsugoe
Surgical Infections.2017; 18(2): 149. CrossRef
Efforts to Prevent Surgical Site Infection After Colorectal Surgery
Byung Wook Min
Annals of Coloproctology.2015; 31(6): 211. CrossRef

First
Prev
Page of 1
Next
Last

Search